###begin article-title 0
CFTR Is a Negative Regulator of NFkappaB Mediated Innate Immune Response
###end article-title 0
###begin p 1
Conceived and designed the experiments: NV. Performed the experiments: NV SM. Analyzed the data: NV SM PLZ. Contributed reagents/materials/analysis tools: NV PLZ. Wrote the paper: NV. Helped with the editing of the paper: PLZ.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Dysfunctional CFTR in the airways is associated with elevated levels of NFkappaB mediated IL-8 signaling leading to neutrophil chemotaxis and chronic lung inflammation in cystic fibrosis. The mechanism(s) by which CFTR mediates inflammatory signaling is under debate.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 1352 1359 1322 1329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1437 1450 1407 1420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1437 1450 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1480 1484 <span type="species:ncbi:10090">mice</span>
###xml 1763 1767 <span type="species:ncbi:10090">mice</span>
We tested the hypothesis that wt-CFTR down-regulates NFkappaB mediated IL-8 secretion. We transiently co-expressed wt-CFTR and IL-8 or NFkappaB promoters driving luciferase expression in HEK293 cells. Wt-CFTR expression in HEK293 cells suppresses both basal and IL1beta induced IL-8, and NFkappaB promoter activities as compared to the control cells transfected with empty vector (p<0.05). We also confirmed these results using CFBE41o- cells and observed that cells stably transduced with wt-CFTR secrete significantly lower amounts of IL-8 chemokine as compared to non-transfected control cells. To test the hypothesis that CFTR must be localized to cell surface lipid rafts in polarized airway epithelial cells in order to mediate the inflammatory response, we treated CFBE41o- cells that had been stably transduced with wt-CFTR with methyl-beta-cyclodextrin (CD). At baseline, CD significantly (p<0.05) induced IL-8 and NFkappaB reporter activities as compared to control cells suggesting a negative regulation of NFkappaB mediated IL-8 signaling by CFTR in cholesterol-rich lipid rafts. Untreated cells exposed to the CFTR channel blocker CFTR-172 inhibitor developed a similar increase in IL-8 and NFkappaB reporter activities suggesting that not only must CFTR be present on the cell surface but it must be functional. We verified these results in vivo by comparing survival, body weight and pro-inflammatory cytokine response to P. aeruginosa LPS in CFTR knock out (CFKO) mice as compared to wild type controls. There was a significant (p<0.05) decrease in survival and body weight, an elevation in IL-1beta in whole lung extract (p<0.01), as well as a significant increase in phosphorylated IkappaB, an inducer of NFkappaB mediated signaling in the CFKO mice.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
Our data suggest that CFTR is a negative regulator of NFkappaB mediated innate immune response and its localization to lipid rafts is involved in control of inflammation.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 289 292 289 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Rowe1">[1]</xref>
###xml 566 569 562 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Thibodeau1">[2]</xref>
###xml 951 954 943 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Zaman1">[3]</xref>
###xml 574 582 <span type="species:ncbi:9606">patients</span>
###xml 743 751 <span type="species:ncbi:9606">patients</span>
Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR), a cAMP dependent and ATP-gated chloride channel that regulates epithelial surface fluid secretion in respiratory and gastrointestinal tracts [1]. Deletion of phenylalanine at position 508 (DeltaF508) in CFTR is the most common cystic fibrosis causing mutation, resulting in a temperature sensitive folding defect, retention of the protein in the endoplasmic reticulum (ER) and subsequent degradation by the proteasome [2]. CF patients exhibit a typical phenotype that is characterized by persistent pulmonary infections, leading to pulmonary failure and death. Bronchoalveolar fluid (BAL) in CF patients contains increased levels of proinflammatory cytokines and neutrophils. CF cells have increased basal levels of pro-inflammatory C-X-C chemokine, interleukin (IL)-8, attributed to activated NFkappaB [3].
###end p 9
###begin p 10
###xml 71 74 71 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Yoshimura1">[4]</xref>
###xml 167 170 167 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Nakamura1">[5]</xref>
###xml 208 211 208 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Donnelly1">[6]</xref>
###xml 270 273 270 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Marini1">[7]</xref>
###xml 349 352 349 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Standiford1">[8]</xref>
###xml 670 673 670 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Armstrong1">[9]</xref>
###xml 674 678 674 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Konstan1">[11]</xref>
###xml 865 869 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-DiMango1">[12]</xref>
###xml 871 875 856 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Massion1">[13]</xref>
IL-8, the C-X-C chemokine, is a potent chemoattractant for neutrophils [4] that has been implicated in a number of inflammatory diseases, such as cystic fibrosis (CF) [5], adult respiratory distress syndrome [6], chronic obstructive pulmonary disease (COPD), and asthma [7]. The airway epithelium is one of the several sources of IL-8 in the airway [8]. The airway epithelium serves as a barrier against invading microorganisms. Airway epithelial release of IL-8 contributes to host defense by promoting neutrophil chemotaxis and airway inflammation. The exaggerated inflammatory responses in chronic diseases such as CF contribute to neutrophil-driven lung destruction [9]-[11]. Several cytokines such as IL1-beta, tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma and bacterial products, induce NFkappaB mediated IL-8 release from airway epithelial cells [12], [13], thus exacerbating the baseline inflammatory milieu in CF.
###end p 10
###begin p 11
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Rubin1">[14]</xref>
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Rubin2">[15]</xref>
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Machen1">[16]</xref>
###xml 394 398 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Tseng1">[17]</xref>
###xml 604 608 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Rubin1">[14]</xref>
Although it has been almost two decades since the identification of the CFTR gene, we still do not fully understand the progression from chronic inflammation to bronchiectasis and end-stage CF lung disease[14], [15]. Excessive inflammation in the CF airway may be largely responsible for the development of bronchiectasis, but it has not been clear if chronic infection is always a factor[16], [17]. Several studies have shown that dysfunctional CFTR in the airways is associated with the elevated levels of NFkappaB mediated IL-8 signaling leading to neutrophil chemotaxis and chronic lung inflammation [14]. However, there is little consensus on the mechanism(s) which link mutant CFTR to chronic lung inflammation. In this study, we tested the hypothesis that functional CFTR on cell surface and its localization to cholesterol-rich lipid rafts is required for controlling both NFkappaB activity and downstream inflammatory signaling. Our results show that the expression of functional CFTR on cell surface negatively regulates the NFkappaB mediated innate immune response.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
CFTR negatively regulates NFkappaB and IL-8 signaling
###end title 13
###begin p 14
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Vij1">[18]</xref>
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Perez1">[20]</xref>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-DiMango2">[21]</xref>
###xml 390 412 390 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Heeckeren1">[22]</xref>
###xml 662 684 651 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 791 799 773 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 947 952 922 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g001">Fig 1</xref>
###xml 1538 1543 1495 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g002">Fig 2</xref>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 227 232 <span type="species:ncbi:9606">human</span>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
###xml 390 412 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 662 684 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
We and others have demonstrated that epithelial secretion of interleukin (IL)-8 is elevated at baseline in bronchial epithelial cells from human CF subjects [18]-[20]. This hyper-inflammatory response was also observed in both human CF respiratory epithelial cell lines[21] and in CF transmembrane conductance regulator deficient homozygous mice (CFTR-/-) compared to normal controls after Pseudomonas aeruginosa stimulation [22]. To study the link between CFTR and NFkappaB activation, we over-expressed wt-CFTR in HEK293 cells and verified transfection efficiency by cell surface immunofluorescence microscopy. We tested the response to IL1-beta, TNFalpha and Pseudomonas aeruginosa LPS by induction of NFkappaB- or IL-8- reporter activities (1.2-2 fold) and selected IL1-beta for further in vitro studies based on its prominent and stable proinflammatory stimulus. In baseline conditions and after stimulation with IL-1beta, IL-8 and NFkappaB (Fig 1) promoter-driven luciferase expression was suppressed greater than 2 fold by wt-CFTR as compared to the control cells transfected with empty vector (p<0.05). In cells co-transfected with the IL-8-DeltaNFkappaB promoter, in which we deleted the NFkappaB transcription site, wt-CFTR no longer reduced the IL-8 promoter activity. We also verified these results by quantitation of basal and IL1-beta induced IL-8 chemokine secretion in CFBE41o- and CFBE41o-wt-CFTR cells. Stable wt-CFTR expression blunts the basal (p<0.05) and IL1-beta induced IL-8 chemokine secretion in CFBE41o- cells (Fig 2). Our results confirm that CFTR negatively regulates NFkappaB mediated IL-8 signaling.
###end p 14
###begin title 15
CFTR downregulates IL-8 and NFkappaB reporter activities.
###end title 15
###begin p 16
HEK293 cells were transiently transfected with wt-CFTR and IL-8 (A) or NFkappaB (B) reporter constructs together with a renila luciferase internal control plasmid (n = 3). The cells were induced with 1 ng/ml IL1-beta overnight. Data are normalized to the renila luciferase internal control and expressed as mean+/-SD. A. IL-8 promoter driven luciferase expression. IL1-beta stimulates IL-8 promoter activity and wt-CFTR blunts both control and IL1-1beta driven IL-8 (*p<0.05). B. NFkappaB driven luciferase expression. IL-1beta stimulates NFkappaB promoter activity and wt-CFTR blunts both control and IL-1-beta driven NFkappaB (*p<0.05).
###end p 16
###begin title 17
CFTR downregulates IL-8 chemokine secretion.
###end title 17
###begin p 18
CFBE41o- control and cells stably transduced with wt-CFTR were induced with 1 ng/ml IL1-beta and IL-8 chemokine secretion in media was calculated after overnight treatment. Data are shown as mean+/-SD of three experiments. IL1-beta stimulates IL-8 chemokine secretion while wt-CFTR blunts both control and IL1-1beta driven IL-8 chemokine secretion (*p<0.05).
###end p 18
###begin title 19
Localization of CFTR in lipid rafts is required to regulate NFkappaB and IL-8 signaling
###end title 19
###begin p 20
###xml 186 190 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Dudez1">[23]</xref>
###xml 432 436 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Dudez1">[23]</xref>
###xml 998 1004 983 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g003">Fig 3A</xref>
###xml 1164 1170 1145 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004664.s001">Fig S1</xref>
###xml 1415 1421 1384 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004664.s002">Fig S2</xref>
###xml 1699 1713 1662 1676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g003">Fig 3B, p&lt;0.05</xref>
###xml 1976 1998 1935 1957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 1976 1998 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 2012 2017 <span type="species:ncbi:9606">human</span>
###xml 2033 2039 <span type="species:ncbi:10090">murine</span>
It was recently reported that methyl-beta-cyclodextrin (CD), a membrane cholesterol scavenger reduces both the basal and stimulated amount of CFTR in detergent resistant membranes (DRMs)[23]. The absence of CFTR in DRMs was associated with abnormal TNFR1 signaling as verified by no recruitment of TNFR1 and c-Src to lipid rafts in CFTR-DeltaTRL cells and loss of regulation of gap junctional communication (GJIC) and IL-8 secretion[23]. These results suggest that localization of CFTR in lipid rafts in association with c-Src and TNFR1 provides a responsive signaling complex to regulate GJIC and cytokine signaling. To verify these results, we used NFkappaB and IL-8 reporter assays to quantify the impact of CFTR inhibition from DRMs in CFBE41o-wt-CFTR cells. Under conditions that deplete CFTR localization to cholesterol-rich lipid rafts, CD treatment significantly induced (>2 fold; p<0.05) NFkappaB and IL8 reporter activities in CFBE41o-wtCFTR cells as compared to control untreated cells (Fig 3A). These data confirm that CFTR is a negative regulator of NFkappaB mediated IL-8 signaling and demonstrates the importance of lipid raft localization of CFTR (Fig S1) for its NFkappaB-regulatory function. We also observed that there is no change in NFkappaB reporter activity with CD treatment in HEK293 cells in absence of CFTR indicating that CD modulates lipid-raft mediated NFkappaB activity through CFTR (Fig S2). We next hypothesized that inhibition of wt-CFTR function with CFTR-172 inhibitor in CFBE41o-wtCFTR cells would produce a similar effect on inflammatory signaling as CD. Treatment with CFTR-172 inhibitor induces NFkappaB (>2 fold) and IL-8 (>/=1.33 fold) reporter activities (Fig 3B, p<0.05) supporting the hypothesis that functional CFTR is required for regulating NFkappaB mediated IL-8 signaling. Our data predicts that the absence of functional CFTR from lipid rafts or cell surface may contribute to a chronic inflammatory state in the presence of Pseudomonas aeruginosa infection in human CF subjects or murine model.
###end p 20
###begin title 21
Inhibition of CFTR regulated NFkappaB signaling under conditions that disrupt lipid rafts.
###end title 21
###begin p 22
###xml 610 616 583 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g001">Figs 1</xref>
###xml 617 618 590 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g002">2</xref>
CFBE41o- cells stably transduced with wt-CFTR were transiently transfected with IL-8 or NFkappaB reporter constructs and a renila luciferase internal control plasmid (n = 3). The cells were induced with 1 ng/ml IL1-beta and/or treated with 5 mM methyl-beta-cyclodextrin (CD) for 6 hrs (A), and/or 10 microM CFTR-172 inhibitor overnight (B). The data are shown as mean+/-SD of IL-8 or NFkappaB promoter activities normalized to renila luciferase internal control. A. IL-1beta induced IL-8 and NFkappaB promoter driven luciferase expression, and wt-CFTR dampened baseline and cytokine induced reporter activity (Figs 1&2). Pre-treatment with CD under conditions known to disrupt lipid rafts eliminated the effect of wt-CFTR, *p<0.05. B. Cells were transfected as in A but instead of treatment with CD, the CFTR-172 inhibitor was included to block CFTR-mediated chloride secretion at the plasma membrane. Pre-treatment with CFTR 172 inhibitor induced IL-8 and NFkappaB promoter activities and eliminated the inhibitory effect of wt-CFTR, *p<0.05.
###end p 22
###begin title 23
CFTR is required for recovery from LPS induced inflammation
###end title 23
###begin p 24
###xml 139 152 139 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 319 332 319 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 374 381 374 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 621 626 621 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g004">Fig 4</xref>
###xml 858 864 858 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004664.s003">Fig S3</xref>
###xml 1013 1018 1013 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g005">Fig 5</xref>
###xml 1175 1183 1175 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1185 1190 1185 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g001">Fig 1</xref>
###xml 1192 1193 1192 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g002">2</xref>
###xml 1194 1195 1194 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g003">3</xref>
###xml 1201 1208 1201 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1210 1215 1210 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g004">Fig 4</xref>
###xml 1216 1217 1216 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g005">5</xref>
###xml 139 152 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 286 290 <span type="species:ncbi:10090">Mice</span>
###xml 319 332 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
###xml 552 556 <span type="species:ncbi:10090">mice</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 693 697 <span type="species:ncbi:10090">mice</span>
###xml 915 919 <span type="species:ncbi:10090">mice</span>
###xml 1043 1047 <span type="species:ncbi:10090">mice</span>
To test the hypothesis that CFTR regulates the proinflammatory response and absence of CFTR results in chronic inflammation in presence of P. aeruginosa, we quantified changes in LPS induced systemic immune response in FABP-gut corrected CFTR knock out (CFKO) and wild type (wt-) mice. Mice (n = 12) were injected with P. aeruginosa LPS or live bacteria as described in the Methods. We compared body weight, survival and pro-inflammatory response in sera and whole lung protein over 7 days in CFKO mice as compared to wild type controls. Wt- and CFKO- mice both experience a significant (p<0.05) decrease in body weight (Fig 4) although wt- mice can recover from weight loss by day 7 but CFKO mice do not. The box and whisker plot analysis of data was used to determine the variation and central tendency of the replicates (body weights) at each time point (Fig S3). Even more striking is the observation that CFKO mice have 25% lower survival (p<0.05) as compared to their wt- counterparts at similar LPS doses (Fig 5). The inability of CFKO mice to recover from weight loss and decreased survival suggest that CFTR is required for systemic immune response to LPS. Both our in vitro (Fig 1, 2&3) and in vivo (Fig 4&5) data clearly indicate the negative correlation between CFTR cell surface levels and NFkappaB mediated inflammatory signaling.
###end p 24
###begin title 25
###xml 19 23 <span type="species:ncbi:10090">mice</span>
The CFTR knock out mice show significant decline in body weight after LPS treatment.
###end title 25
###begin p 26
###xml 121 134 121 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 121 134 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 677 682 <span type="species:ncbi:10090">mouse</span>
###xml 872 876 <span type="species:ncbi:10090">mice</span>
The FABP-CFTR gut corrected CFTR knock-outs (CFKO) and wt- mice (n = 12) were injected i.p. with 15 mg/kg body weight of P. aeruginosa LPS, and body weights were recorded daily for 6 days. The CFKO mice show significant decline in body weight as compared to wild type mice (p<0.001; day 3-6). Wild type mice (blue) recover from weight loss by day 6 while CFKO mice (red) don't show significant recovery. The 25% of CFKO mice died during the course of experiment due to LPS induced chronic inflammation (green). The data suggest that CFTR is critical for LPS induced immune response and recovery from LPS induced inflammation. The data are shown as body weight in grams of each mouse in wt- and CFKO- group from day 0 to 6. The non-linear logarithmic regression was used to calculate the trend lines indicating the changes in body weight in wild type (blue) and CFKO (red) mice after LPS exposure.
###end p 26
###begin title 27
###xml 19 23 <span type="species:ncbi:10090">mice</span>
The CFTR knock out mice show significant decline in recovery from inflammation after LPS treatment.
###end title 27
###begin p 28
###xml 121 134 121 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 121 134 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
The FABP-CFTR gut corrected CFTR knock-outs (CFKO) and wt- mice (n = 12) were injected i.p. with 15 mg/kg body weight of P. aeruginosa LPS, and survival was recorded daily for 7 days. The data are shown as percentage of mice that survived at each time point. The CFKO mice (red) show a 25% decline in survival as compared to wild type mice (blue) by day 4 (*p<0.05). Wild type mice show 100% survival and recovery from inflammation at the given LPS dose while 25% of CFKO mice fail to recover and don't survive.
###end p 28
###begin title 29
###xml 78 84 <span type="species:ncbi:10090">murine</span>
CFTR negatively regulates IkappaB-NFkappaB mediated inflammatory signaling in murine lung
###end title 29
###begin p 30
###xml 137 150 125 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 444 452 417 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g006">Fig 6A&amp;B</xref>
###xml 1226 1232 1169 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g006">Fig 6B</xref>
###xml 1301 1314 1241 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 1789 1793 1689 1693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Ostedgaard1">[24]</xref>
###xml 1975 1979 1867 1871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Ostedgaard1">[24]</xref>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 137 150 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 335 341 <span type="species:ncbi:10090">murine</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 655 659 <span type="species:ncbi:10090">mice</span>
###xml 846 850 <span type="species:ncbi:10090">mice</span>
###xml 1191 1195 <span type="species:ncbi:10090">mice</span>
###xml 1301 1314 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1341 1345 <span type="species:ncbi:10090">mice</span>
###xml 1514 1518 <span type="species:ncbi:10090">mice</span>
###xml 1675 1681 <span type="species:ncbi:10090">murine</span>
###xml 1767 1772 <span type="species:ncbi:9606">human</span>
###xml 1827 1831 <span type="species:ncbi:10090">mice</span>
###xml 1888 1894 <span type="species:ncbi:9606">humans</span>
###xml 1938 1944 <span type="species:ncbi:10090">murine</span>
We hypothesized that the activated phosphorylated form of IkappaBalpha (an inducer of NFkappaB) would be increased in CF mice exposed to P. aeruginosa LPS or bacteria, and that wt-mice would have lower levels because CFTR was negatively regulating signaling via TNFalpha-IL-1beta-TLR. We measured phosphorylated IkappaBalpha levels in murine lungs by immunoblotting of whole lung protein extracts from the CFKO- and wt- mice. As can be seen in Fig 6A&B, there was a significant increase in phosphorylated IkappaBalpha from CFKO lung (p<0.01), as compared to the wild types (n = 3). At this exposure level of the blot we did not see any signal from the wt-mice. We quantified 4.5-fold (p<0.05, n = 3) increase in IkappaBalpha-p protein levels in CFKO lungs over wt- that verifies the significant increase in baseline IkappaBalpha-p levels in CFKO mice. The proinflammatory stimulus (LPS or bacteria), do not aggravate this increase. We then measured changes in downstream proinflammatory signaling by quantifying IL1-beta cytokine levels and observed a steep increase by 6 hrs of LPS treatment. Both 6 and 24 hrs LPS treatments result in significantly higher IL1-beta cytokine levels in CFKO mice as compared to the wild type (Fig 6B). We also observed a significant induction of IL1-beta by 24 hrs of P. aeruginosa LPS in DeltaF508- and wt- mice (approximately1.2-2 fold; p<0.01) although this induction was much lower than seen in CFKO (approximately10 fold; p<0.01) in a parallel experiment. Moreover, DeltaF508-mice showed 100% survival after LPS induced inflammation, similar to the wild types. This observation can be explained by a recent report that demonstrates that murine DeltaF508-CFTR is more efficient at trafficking to the cell surface when compared to human DeltaF508- CFTR [24]. Hence we suspect that DeltaF508-mice fail to mimic the severe inflammatory phenotype seen in humans with CF in part because the trafficking of murine DeltaF508- is more efficient. [24].
###end p 30
###begin title 31
###xml 19 23 <span type="species:ncbi:10090">mice</span>
The CFTR knock out mice have elevated IkappaB-NFkappaB mediated inflammatory signaling.
###end title 31
###begin p 32
###xml 120 133 120 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 172 173 168 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 120 133 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
###xml 628 632 <span type="species:ncbi:10090">mice</span>
###xml 763 767 <span type="species:ncbi:10090">mice</span>
###xml 932 936 <span type="species:ncbi:10090">mice</span>
The FABP-CFTR gut corrected CFTR knock-outs (CFKO) and wt- mice (n = 3) were injected i.p. with 15 mg/kg body weight of P. aeruginosa LPS or live bacteria (100 microl, 2x108), and IkappaB-p levels (24 hrs) were quantified by immunoblotting while serum IL1-beta levels (6 or 24 hrs) were determined by ELISA. A. The representative immunoblot indicates the IkappaB-p protein levels in each group. The lung protein extracts of CFKO mice show inherent increase in IkappaB-p levels indicative of elevated NFkappaB signaling and activation. The densitometry analysis of IkappaB-p protein levels in CFKO lungs as compared to wild type mice show a 4.5 fold increase (n = 3, p<0.05) at baseline. B. The serum concentration of IL1-beta (pg/ml) shown as mean+/-SD. The CFKO mice (red) have significantly higher pro-inflammatory cytokine, IL1-beta, levels (***p<0.001 at 6 hrs while *p<0.05 at 24 hrs) on LPS induction as compared to wild type mice (green; **p<0.01).
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 469 473 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Blackwell1">[25]</xref>
###xml 474 478 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Joseph1">[29]</xref>
The cystic fibrosis transmembrane conductance regulator (CFTR) gene was identified nearly two decades ago, however it remains unclear whether chloride transport through CFTR is a critical regulator of both epithelial fluid balance and inflammatory signaling. Numerous studies have shown that inflammatory signaling through the NFkappaB pathway is increased in CF lungs and that this is linked to the production of pro-inflammatory cytokines such as interleukin-8 (IL-8)[25]-[29]. However, there is little consensus on the mechanism(s) which link CFTR or its heritable mutant forms to chronic lung inflammation. In this study, we tested the hypothesis that wild-type CFTR regulates NFkappaB activity and IL-8 chemokine secretion. Our results show that CFTR cell surface expression, lipid raft localization and uninhibited channel function correlates inversely with NFkappaB and IL-8 promoter activities, and downstream inflammatory signaling.
###end p 34
###begin p 35
###xml 176 183 172 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 691 699 663 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g001">Fig 1A&amp;B</xref>
###xml 763 766 735 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 1004 1010 960 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004664.s001">Fig S1</xref>
###xml 1052 1058 1008 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g003">Fig 3A</xref>
###xml 192 198 <span type="species:ncbi:10090">murine</span>
###xml 1117 1125 <span type="species:ncbi:9606">patients</span>
###xml 1923 1931 <span type="species:ncbi:9606">patients</span>
We first demonstrated that in both unpolarized and polarized epithelial cells, CFTR is a negative regulator of NFkappaB mediated inflammatory signaling. In a much more complex in vivo system, murine model, we confirmed that CFTR is a negative regulator of the NFkappaB mediated response and absence of CFTR results in an inherent defect in IkappaB-NFkappaB mediated innate immune response. To investigate the precise role of CFTR in regulation of NFkappaB mediated IL-8 signaling we quantified NFkappaB and IL-8 reporter activities in HEK293 and CFBE41o- cells in the presence and absence of wt-CFTR. We observed that wt-CFTR negatively regulates both NFkappaB and IL-8 promoter activities (Fig 1A&B). We also confirmed that CFTR regulates IL-8 reporter activity via NFkappaB by using DeltaNFkappaB-IL-8 promoter and observed that deletion of NFkappaB site in IL-8 promoter releases the inhibitory effect of CFTR on IL-8 promoter activity. Moreover, we demonstrate that CFTR localization to lipid rafts (Fig S1) is involved in control of inflammation (Fig 3A). Our data supports the view that in cystic fibrosis (CF) patients with DeltaF508-mutation, the absence of CFTR from lipid rafts or the cell surface results in chronic inflammation and lung disease. This data indicates that CFTR has anti-inflammatory properties and that the hyper-inflammation found in CF is in part due to a disruption of the signaling link between CFTR and NFkappaB. This is contrary to the concept that inflammation in the CF lung is entirely due to the loss of chloride and sodium transport causing impaired mucociliary clearance. Further work is required to determine whether rescue of a partially functional CFTR will favorably impact the balance of physiological and inflammatory pathways. A better understanding of these pathways could lead to new treatments for inflammation in CF, resulting in prolonged better quality of life for these patients.
###end p 35
###begin p 36
###xml 351 357 343 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 486 487 478 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 630 634 614 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Weber1">[30]</xref>
###xml 689 690 673 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 829 830 813 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1500 1504 1464 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Dudez1">[23]</xref>
###xml 2137 2143 2074 2080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004664.s004">Fig S4</xref>
###xml 2202 2206 2139 2143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Bartoszewski1">[31]</xref>
###xml 2207 2211 2144 2148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Rab1">[33]</xref>
###xml 2343 2347 2276 2280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Bartoszewski1">[31]</xref>
###xml 2348 2352 2281 2285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Rab1">[33]</xref>
###xml 2474 2480 2403 2409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004664.s004">Fig S4</xref>
Although it is currently not clear how mutations in CFTR lead to abnormalities of the NFkappaB pathway, our findings demonstrate that lack of functional CFTR on cell surface and not just accumulation of misfolded CFTR in the endoplasmic reticulum or some other by-product of the CTFR mutation leads to abnormal function of the NFkappaB pathway. Weber et al. recently evaluated cells with CFTR mutations that produce proteins that are trafficked normally to the cell membrane but lack Cl- channel function. The G551D and DeltaF508 mutations were associated with up regulation of NFkappaB activation and increased production of IL-8[30]. They concluded that cell lines with defective CFTR Cl- channel activity, regardless of the type of CFTR defect, have a proinflammatory phenotype. Elucidating the mechanisms by which abnormal Cl- channel function deregulates NFkappaB activation in CF is an important area for further investigation. Recently, Marc Chanson, Bruce Stanton and colleagues demonstrated that deletion of the PDZ binding domain of CFTR (CFTR-DeltaTRL) not only compromises the ability of CFTR to localize to gap junction TNFalpha protein-complex but also results in activation of downstream NFkappaB signaling. The absence of CFTR in detergent resistant membranes (DRMs) was associated with abnormal TNFR1 signaling as verified by lack of recruitment of TNFR1 and c-Src to lipid rafts in CFTR-DeltaTRL cells and loss of regulation of gap junctional communication (GJIC) and IL-8 secretion[23]. These results suggest that localization of CFTR in detergent resistant and cholesterol rich lipid rafts in association with c-Src and TNFR1 provides a responsive signaling complex to regulate GJIC and NFkappaB mediated cytokine signaling. This supports the idea that when DeltaF508 CFTR is inefficient in trafficking, there is exaggerated NFkappaB mediated signaling due to lack of gap junctional communication (GJIC) of CFTR with TNFalpha or IL1-beta receptors. We and others have observed that transient or stable over expression of DeltaF508-CFTR in HEK-293 or CFBE cells results in decreased NFkappaB transcriptional activity (Fig S4), but expression of another type of CFTR mutation does not[31]-[33]. In spite of the fact that over expression of misfolded DeltaF508 CFTR results in endoplasmic reticulum overload and UPR activation[31]-[33], we anticipate that cell surface expression of over expressed mutant CFTR will inhibit the NFkappaB activity (as seen in Fig S4) and this warrants further investigation.
###end p 36
###begin p 37
###xml 386 390 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Blackwell1">[25]</xref>
###xml 391 395 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Joseph1">[29]</xref>
###xml 495 517 487 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 591 604 583 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 684 688 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Schroeder1">[34]</xref>
###xml 690 694 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Schroeder2">[35]</xref>
###xml 786 790 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Reiniger1">[36]</xref>
###xml 1109 1115 1078 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g006">Fig 6A</xref>
###xml 1529 1535 1491 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g003">Fig 3A</xref>
###xml 1536 1537 1498 1499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g006">6</xref>
###xml 1542 1548 1504 1510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004664.s001">Fig S1</xref>
###xml 1695 1699 1657 1661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Collaco1">[37]</xref>
###xml 1700 1704 1662 1666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Knowles1">[39]</xref>
###xml 1710 1718 1672 1680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1723 1730 1685 1692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1965 1970 1923 1928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004664-g007">Fig 7</xref>
###xml 495 517 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 591 604 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 808 816 <span type="species:ncbi:9606">patients</span>
###xml 1047 1051 <span type="species:ncbi:10090">mice</span>
NFkappaB mediated IL-8 chemokine secretion and neutrophil influx, are prominent and early features of CF. It is proposed that airway inflammation may occur before or in the absence of bacterial infection. Several recent reports have demonstrated that lung epithelial cells expressing mutant CFTR have increased production of proinflammatory cytokines and exaggerated NFkappaB-activation[25]-[29]. GB Pier and colleagues have demonstrated a role for CFTR in airway epithelial cell endocytosis of Pseudomonas aeruginosa. They proposed that CFTR is a pattern recognition molecule that extracts P. aeruginosa LPS from outer membrane into epithelial cells and activates NFkappaB signaling [34], [35]. They hypothesize that the lack of this initial IL1-beta-NFkappaB proinflammatory signaling[36] in DeltaF508- CF patients results in chronic airway inflammation. In contrast, other groups believe that CFTR dysfunction in CF results in exaggerated NFkappaB signaling that leads to chronic lung disease. Our data for the first time demonstrate that CFKO mice have inherently higher levels of phosphorylated IkappaB (Fig 6A) supporting the notion that lack of CFTR results in hyper-inflammatory signaling by compromising the regulatory mechanisms of innate immunity. In addition, we observed that cell surface localization of CFTR is required for regulation of gap junction communication (GJIC) and response to pathogen associated molecular patterns (PAMPs) by primary signaling receptors (TNFalpha, IL1-beta or TLRs) of innate defense (Fig 3A&6 and Fig S1). This may explain why mutations or single nucleotide polymorphisms (SNPs) of these receptors have the modifier function in CF or CF like diseases[37]-[39]. Our in vitro and in vivo data clearly support the hypothesis that CFTR serves as a negative regulator of innate immunity and both CFTR channel function and its localization to lipid rafts are critical for controlling NFkappaB mediated inflammatory signaling (Fig 7).
###end p 37
###begin title 38
Hypothetical model of CFTR mediated NFkappaB signaling and innate immune response.
###end title 38
###begin p 39
###xml 162 165 159 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
The lack of functional CFTR on the cell surface or inhibition of lipid raft localization by methyl-beta-cyclodextrin (CD) de-regulates pro-inflammatory signaling via TNFalpha-IL1beta-TLR pathways resulting in an overactive innate immune response, chronic NFkappaB mediated inflammation, and lung destruction. Our data suggest that localization of functional CFTR at the cell surface in cholesterol rich lipid rafts serves as a negative regulator of NFkappaB signaling. We propose that restoration of an optimal amount of functional CFTR on the cell surface can control chronic inflammatory pathophysiology of CF lung disease by not only restoring the chloride efflux function but by also regulating the chronic NFkappaB mediated inflammatory signaling.
###end p 39
###begin p 40
###xml 85 98 85 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Dudez1">[23]</xref>
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Kowalski1">[40]</xref>
###xml 85 98 <span type="species:ncbi:287">P. aeruginosa</span>
Recent studies have shown that localization of CFTR to DRMs increases in presence of P. aeruginosa or proinflammatory stimulus[23], [40], we anticipate that this may be a homeostatic mechanism to control inflammation. We also observed that not only CFTR channel expression and its localization to DRMs but also its channel function is required to control inflammation. There can be two possible scenarios where CFTR channel function can regulate proinflammatory response: 1.) cell surface or 2.) DRMs. The mechanism of first scenario is apparent but it is not clear if functional CFTR is required in DRMs, we predict that non-functional channels may be incapable of localization to DRMs in presence of proinflammatory stimulus resulting in uncontrolled inflammatory response. We are further investigating the role of CFTR channel function in its DRM localization.
###end p 40
###begin p 41
###xml 240 248 <span type="species:ncbi:9606">patients</span>
Together, these studies suggest a mechanism that links CFTR localization in lipid rafts, and channel function to intracellular NFkappaB signaling and inflammatory response. The clinical implication of these findings is that treatment of CF patients with small molecule or therapeutic compounds that rescues optimal amount of mutant CFTR to the cholestrol-rich cell surface lipid rafts can inhibit the NFkappaB mediated chronic inflammation and rescue the pathology induced by defective CFTR, potentially attenuating the progression of CF or related obstructive lung diseases like COPD and emphysema.
###end p 41
###begin title 42
Materials and Methods
###end title 42
###begin title 43
Cell Culture and Reagents
###end title 43
###begin p 44
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Cozens1">[41]</xref>
###xml 141 145 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Bruscia1">[42]</xref>
###xml 253 257 245 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-HentchelFranks1">[43]</xref>
###xml 818 840 784 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 922 944 888 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 466 472 <span type="species:ncbi:9913">bovine</span>
###xml 818 840 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 903 907 <span type="species:ncbi:10090">mice</span>
###xml 922 949 <span type="species:ncbi:208964">Pseudomonas aeruginosa PAO1</span>
The HEK293, CFBE41o- (cystic fibrosis bronchial epithelial cell lines, originally immortalized and characterized by Dr. Dieter Gruenert[41], [42]), CFBE41o-wtCFTR or CFBE41o-DeltaF08-CFTR (stably transduced with wt-CFTR or DeltaF08-CFTR by Dr. JP Clancy[43]) cell lines were maintained in DMEM/F12 and MEM Earl's salt L-Glutamine (200 mM L-Glutamine) medium containing 100 units/ml penicillin, 100 microg/ml streptomycin, 0.25 microg/ml amphotericin B and 10% fetal bovine serum. The CFBE41o-wtCFTR or CFBE41o-DeltaF08-CFTR cells were always cultured in presence of 500 microg/ml Hygromycin B. DMEM/F12, MEM and other components were purchased from Gibco or Invitrogen, Carlsbad, CA. TNF-alpha, IL-1beta (R&D Systems Inc., Minneapolis, MN), CFTR-172 inhibitor (Calbiochem, Gibbstown, NJ), methyl-beta-cyclodextrin and Pseudomonas aeruginosa LPS (Sigma, St. Louis, MO) were added to cells or injected in mice as indicated. Pseudomonas aeruginosa PAO1 strain was obtained from ATCC for animal experiments. Sulfo-NHS-SS-Biotin was purchased from Pierce, Rockford, IL while other common laboratory chemicals were from Sigma.
###end p 44
###begin title 45
Immunoblotting
###end title 45
###begin p 46
###xml 528 534 <span type="species:ncbi:9986">rabbit</span>
Lung tissues were lysed by sonication (three 5 sec pulses) on ice in cold room using the T-PER (Pierce Biotech. Inc., Rockford, IL) protein lysis buffer containing protease-inhibitor cocktail (Pierce). The protein extracts were suspended in Laemmli's sample buffer (Invitrogen) containing beta-mercaptoethanol (Invitrogen), resolved by 4-10% SDS-PAGE and transferred to a 0.45 microm pore size nitrocellulose membrane (Invitrogen). The beta-actin (Sigma) and IkappaB-p (Cell Signaling, Danvers, MA) primary antibodies, and anti-rabbit-HRP secondary antibody (Amersham, Piscataway, NJ) were used for immunoblotting.
###end p 46
###begin title 47
Animal Experiments
###end title 47
###begin p 48
###xml 184 191 184 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 357 370 353 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 726 739 719 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 767 768 760 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 357 370 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 726 739 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
All animal experiments were carried out in accordance with the Johns Hopkins University (JHU) Animal Care and Use Committee (ACUC) approved protocol. To measure inflammatory signaling in vivo, the age and sex matched C57BL6, FABP-CFTR gut corrected CFTR knock-outs, DeltaF508-homozygous and wt- mice (n = 12) were injected i.p. with 15 mg/kg body weight of P. aeruginosa LPS, and survival and body weights were recorded daily for 6-7 days. Serum and total lung protein extracts were isolated at 6 and 24 hrs time points in a parallel experiment. Serum IL1-beta cytokine levels were quantified by sandwich ELISA (described below) to identify the changes in pro-inflammatory signaling. The total lung protein extracts from both P. aeruginosa LPS and live bacteria (2x108) injected (i.p.) mice were used for quantification of IkappaB-p and beta-actin protein levels by Western blotting.
###end p 48
###begin title 49
IL-1beta and IL-8 Immunoassay
###end title 49
###begin p 50
###xml 878 882 867 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004664-Vij1">[18]</xref>
At the indicated time points, serum was collected and IL-1beta levels were measured using solid-phase ELISA (R&D Bisoystems, Minneapolis, MN). Standards, and high and low cytokine controls were included. The plates were read at 450 nm on 96-well microplate reader (Molecular Devices, Sunnyvale, CA) using SOFT-MAX-Pro software (Molecular Devices). The mean blank reading was subtracted from each sample and control reading. The amount of substrate turnover was determined calorimetrically by measuring the absorbance which is proportional to IL-1beta concentration. A standard curve was plotted and an IL-1beta concentration in each sample was determined by interpolation from standard curve. The data represents the mean of three independent experiments+/-SD. The IL-8 chemokine secretion in media was similarly quantified using an EASIA system (Invitrogen) as described before[18].
###end p 50
###begin title 51
Transfection, NFkappaB- and IL-8- Reporter Assays
###end title 51
###begin p 52
###xml 545 567 526 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas aeruginosa</italic>
###xml 545 567 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
CFBE41o- or HEK293 cells were transfected with NFkappaB- or IL-8- (with or without the NFkappaB site) firefly luciferase promoter (pGL-2) and renila luciferase (pRLTK) control, or CFTR (wt- or DeltaF508- GFP) constructs. Renila luciferase internal control was used for normalization of DNA and transfection efficiency of reporter constructs in all experiments. Transfection efficiency of CFTR constructs and surface localization of wt-CFTR was verified by immunofluorescence microscopy. Cells were induced with 1 ng/ml of IL1-beta, TNF-alpha or Pseudomonas aeruginosa LPS and luciferase activities were measured after overnight treatment. The 10 microM CFTR-172 inhibitor overnight or 5 mM methyl-beta-cyclodextrin (CD) 6 hrs, treatment was used to inhibit the wt-CFTR function or its localization to lipid rafts, respectively. Dual-Luciferase(R) Reporter (DLRTM) Assay System (Promega) was used to measure NFkappaB or IL-8 reporter (firefly luciferase) and renila luciferace activities from HEK293 or CFBE41o- cell extracts. Data was normalized with internal renila luciferase control for each sample and the changes in reporter activities with CFTR over expression were calculated.
###end p 52
###begin title 53
Statistical Analysis
###end title 53
###begin p 54
###xml 324 325 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Representative data is shown as the mean+/-SD of at least three experiments. The one-way ANOVA with a Dunnett planned comparison was run for each sample versus control. The Box and Whisker plot analysis was used to determine the variation in body weights overtime and central inclination of data among the two genotypes. A *p<0.05 was considered to have statistical significance.
###end p 54
###begin title 55
Supporting Information
###end title 55
###begin p 56
In the absence of CFTR, disruption of lipid rafts does not modulate NFkappaB signaling. HEK293 cells were transiently transfected with NFkappaB reporter construct and a renila luciferase internal control plasmid (n = 3). The cells were induced with 1 ng/ml IL1-beta and/or treated with 5 mM methyl-beta-cyclodextrin (CD) for 6 hrs. The data are shown as mean+/-SD of NFkappaB promoter activity normalized to renila luciferase internal control. IL-1beta induced NFkappaB promoter driven luciferase expression, and CD treatment under conditions known to disrupt lipid rafts has no significant effect on NFkappaB promoter activity in the absence of CFTR.
###end p 56
###begin p 57
(0.69 MB EPS)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin p 59
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 730 734 <span type="species:ncbi:10090">mice</span>
###xml 764 768 <span type="species:ncbi:10090">mice</span>
###xml 809 813 <span type="species:ncbi:10090">mice</span>
###xml 863 867 <span type="species:ncbi:10090">mice</span>
Box and whisker plot analysis of the CFTR knock out mice show significant decline in body weight after LPS treatment. The Box and whisker plot analysis was used to determine the variation and central tendency of data at each time point. The box represents the distance between the 1st and 3rd quartiles (Q). The whiskers show the highest and lowest data points or 1.5 times the box (Q3-Q1). Outlier points (X) are those that are greater than 1.5 times (Q3 -Q1). The yellow box represents the difference between the Q3 and the median while green box indicates the difference between the Q1 and the median. The data shows the statistical significance of the decline in body weights of FABP-CFTR gut corrected CFTR knock-outs (CFKO) mice as compared to the wild type mice (n = 12) from day 0 to 6. (A) Wild type mice recover from weight loss by day 6 while (B) CFKO mice don't show significant recovery.
###end p 59
###begin p 60
(1.19 MB EPS)
###end p 60
###begin p 61
Click here for additional data file.
###end p 61
###begin p 62
Disruption of detergent resistant membranes (DRMs) by methyl-beta-cyclodextrin (CD) inhibits raft CFTR. CFBE41o- cells stably transduced with wt-CFTR were treated with 5 mM methyl-beta-cyclodextrin (CD) for 6 hrs. The plasma membrane proteins biotinylated with 1 mg/ml sulfo-NHS-SS-biotin for 60 min at 37degreesC were isolated by Streptavidin-Sepharose pull down. The sucrose density gradient of these biotin labeled membrane proteins was used to isolate lipid raft and soluble fractions followed by CFTR immunoblotting. CD treatment significantly reduces the amount of raft CFTR but has no effect on soluble CFTR. The densitometric analysis (lower panel) of the raft CFTR bands illustrates the inhibitory effect of CD on CFTR localization to lipid raft. The graph shows mean+SD of duplicate experiments (*p<0.05).
###end p 62
###begin p 63
(1.26 MB EPS)
###end p 63
###begin p 64
Click here for additional data file.
###end p 64
###begin p 65
DeltaF508-CFTR downregulates NFkappaB mediated IL-8 reporter activity. CFBE41o- controls and cells stably transduced with DeltaF508-CFTR were transiently transfected with IL-8 or IL8-DeltaNFkappaB reporter constructs and a renila luciferase internal control plasmid (n = 3). The cells were induced with 1 ng/ml IL1-beta overnight. Data are normalized to the internal control and expressed as mean+SD (*p<0.05). IL-1beta induced IL-8 promoter expression and DeltaF508-CFTR dampened baseline and cytokine induced reporter activity. The deletion of NFkappaB transcription site from IL-8 promoter (IL8-DeltaNFkappaB) abolished both IL1-beta meditated IL-8 induction and inhibitory effect of DeltaF508-CFTR.
###end p 65
###begin p 66
(0.75 MB EPS)
###end p 66
###begin p 67
Click here for additional data file.
###end p 67
###begin p 68
We thank Drs. HR Wong and D Teti for providing IL-8 promoter constructs.
###end p 68
###begin title 69
References
###end title 69
###begin article-title 70
Cystic fibrosis.
###end article-title 70
###begin article-title 71
Side chain and backbone contributions of Phe508 to CFTR folding.
###end article-title 71
###begin article-title 72
Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered.
###end article-title 72
###begin article-title 73
###xml 18 23 <span type="species:ncbi:9606">human</span>
Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.
###end article-title 73
###begin article-title 74
###xml 138 143 <span type="species:ncbi:9606">human</span>
Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line.
###end article-title 74
###begin article-title 75
###xml 80 87 <span type="species:ncbi:9606">patient</span>
Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups.
###end article-title 75
###begin article-title 76
###xml 168 176 <span type="species:ncbi:9606">patients</span>
Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma.
###end article-title 76
###begin article-title 77
Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung.
###end article-title 77
###begin article-title 78
###xml 48 55 <span type="species:ncbi:9606">infants</span>
Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis.
###end article-title 78
###begin article-title 79
###xml 48 56 <span type="species:ncbi:9606">children</span>
Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
###end article-title 79
###begin article-title 80
###xml 51 59 <span type="species:ncbi:9606">patients</span>
Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.
###end article-title 80
###begin article-title 81
###xml 8 30 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8.
###end article-title 81
###begin article-title 82
Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro.
###end article-title 82
###begin article-title 83
CFTR is a modulator of airway inflammation.
###end article-title 83
###begin article-title 84
A scientific koan: what is the cause of cystic fibrosis?
###end article-title 84
###begin article-title 85
Innate immune response in CF airway epithelia: hyperinflammatory?
###end article-title 85
###begin article-title 86
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 56 78 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Innate immune responses of human tracheal epithelium to Pseudomonas aeruginosa flagellin, TNF-alpha, and IL-1beta.
###end article-title 86
###begin article-title 87
CHOP transcription factor mediates IL-8 signaling in cystic fibrosis bronchial epithelial cells.
###end article-title 87
###begin article-title 88
Selective Inhibition of Endoplasmic Reticulum-associated Degradation Rescues {Delta}F508-Cystic Fibrosis Transmembrane Regulator and Suppresses Interleukin-8 Levels: THERAPEUTIC IMPLICATIONS.
###end article-title 88
###begin article-title 89
CFTR inhibition mimics the cystic fibrosis inflammatory profile.
###end article-title 89
###begin article-title 90
###xml 36 58 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells.
###end article-title 90
###begin article-title 91
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 91 113 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa.
###end article-title 91
###begin article-title 92
CFTR in a lipid raft-TNFR1 complex modulates gap junctional intercellular communication and IL-8 secretion.
###end article-title 92
###begin article-title 93
Processing and function of CFTR-DeltaF508 are species-dependent.
###end article-title 93
###begin article-title 94
Dysregulated NF-kappaB activation in cystic fibrosis: evidence for a primary inflammatory disorder.
###end article-title 94
###begin article-title 95
###xml 36 41 <span type="species:ncbi:9606">human</span>
Dysregulated cytokine production in human cystic fibrosis bronchial epithelial cells.
###end article-title 95
###begin article-title 96
Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells.
###end article-title 96
###begin article-title 97
Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells.
###end article-title 97
###begin article-title 98
###xml 135 157 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
NF-kappaB activation and sustained IL-8 gene expression in primary cultures of cystic fibrosis airway epithelial cells stimulated with Pseudomonas aeruginosa.
###end article-title 98
###begin article-title 99
Activation of NF-kappaB in airway epithelial cells is dependent on CFTR trafficking and Cl- channel function.
###end article-title 99
###begin article-title 100
Activation of the unfolded protein response by deltaF508 CFTR.
###end article-title 100
###begin article-title 101
The mechanism of cystic fibrosis transmembrane conductance regulator transcriptional repression during the unfolded protein response.
###end article-title 101
###begin article-title 102
Endoplasmic reticulum stress and the unfolded protein response regulate genomic cystic fibrosis transmembrane conductance regulator expression.
###end article-title 102
###begin article-title 103
###xml 53 75 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation.
###end article-title 103
###begin article-title 104
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 67 89 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
###end article-title 104
###begin article-title 105
###xml 14 36 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor.
###end article-title 105
###begin article-title 106
Update on gene modifiers in cystic fibrosis.
###end article-title 106
###begin article-title 107
Genetic modifiers of lung disease in cystic fibrosis.
###end article-title 107
###begin article-title 108
Gene modifiers of lung disease.
###end article-title 108
###begin article-title 109
###xml 119 141 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation.
###end article-title 109
###begin article-title 110
###xml 61 66 <span type="species:ncbi:9606">human</span>
CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells.
###end article-title 110
###begin article-title 111
Isolation of CF cell lines corrected at DeltaF508-CFTR locus by SFHR-mediated targeting.
###end article-title 111
###begin article-title 112
###xml 38 43 <span type="species:ncbi:9606">human</span>
Activation of airway cl- secretion in human subjects by adenosine.
###end article-title 112
###begin p 113
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 113
###begin p 114
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by R025-CR07 and VIJ07IO grants from the Cystic Fibrosis Foundation to NV, and in part by NIH grants R01 HL59410 and CTSA UL RR 025005 to PZ and NV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 114

